[PDF][PDF] Congenital hyperinsulinism: diagnosis and treatment update

H Demirbilek, K Hussain - Journal of clinical research in …, 2017 - jag.journalagent.com
Pancreatic β-cells are finely tuned to secrete insulin so that plasma glucose levels are
maintained within a narrow physiological range (3.5-5.5 mmol/L). Hyperinsulinaemic …

[HTML][HTML] Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus

MG Shaikh, AK Lucas-Herald, A Dastamani… - Frontiers in …, 2023 - frontiersin.org
Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent
hypoglycaemia in infants and young children caused by inappropriate insulin over …

[HTML][HTML] Hyperinsulinemic hypoglycemia in children and adolescents: recent advances in understanding of pathophysiology and management

M Gϋemes, SA Rahman, RR Kapoor… - Reviews in Endocrine …, 2020 - Springer
Hyperinsulinemic hypoglycemia (HH) is characterized by unregulated insulin release,
leading to persistently low blood glucose concentrations with lack of alternative fuels, which …

[HTML][HTML] International guidelines for the diagnosis and management of hyperinsulinism

DD De Leon, JB Arnoux, I Banerjee, I Bergada… - Hormone Research in …, 2024 - karger.com
Background: Hyperinsulinism (HI) due to dysregulation of pancreatic beta-cell insulin
secretion is the most common and most severe cause of persistent hypoglycemia in infants …

[HTML][HTML] An overview of hypoglycemia in children including a comprehensive practical diagnostic flowchart for clinical use

A Casertano, A Rossi, S Fecarotta… - Frontiers in …, 2021 - frontiersin.org
Hypoglycemia is the result of defects/impairment in glucose homeostasis. The main
etiological causes are metabolic and/or endocrine and/or other congenital disorders …

Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management

D Giri, K Hawton, S Senniappan - Journal of Pediatric Endocrinology …, 2022 - degruyter.com
Congenital hyperinsulinism (CHI) is a rare disease characterized by an unregulated insulin
release, leading to hypoglycaemia. It is the most frequent cause of persistent and severe …

Current and emerging agents for the treatment of hypoglycemia in patients with congenital hyperinsulinism

AP De Cosio, P Thornton - Pediatric Drugs, 2019 - Springer
Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycmia in
neonatles and children. The inappropriate secretion of insulin by the pancreatic β-cells …

A multicenter experience with long-acting somatostatin analogues in patients with congenital hyperinsulinism

I van der Steen, ME van Albada, K Mohnike… - Hormone research in …, 2018 - karger.com
Abstract Background/Aims: Congenital hyperinsulinism (CHI) is a rare disease characterized
by recurrent severe hypoglycemia. In the diffuse form of CHI, pharmacotherapy is the …

Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia

B Haris, S Saraswathi… - Therapeutic Advances in …, 2020 - journals.sagepub.com
Hyperinsulinaemic hypoglycaemia (HH) is a biochemical finding of low blood glucose levels
due to the dysregulation of insulin secretion from pancreatic β-cells. Under normal …

[HTML][HTML] Congenital hyperinsulinaemic hypoglycaemia—a review and case presentation

S Krawczyk, K Urbanska, N Biel, MJ Bielak… - Journal of Clinical …, 2022 - mdpi.com
Hyperinsulinaemic hypoglycaemia (HH) is the most common cause of persistent
hypoglycaemia in infants and children with incidence estimated at 1 per 50,000 live births …